Labs / CDMO: development & manufacturing
Viralgen
San Sebastián, Spain · viralgen.com
GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Viralgen is an AAV-based gene therapy CDMO that provides end-to-end manufacturing support from construct optimization and plasmid DNA production through clinical and commercial production. It serves biotech and pharmaceutical clients developing gene therapies for rare, ultra-rare, and other genetic diseases from its facilities in San Sebastián, Spain.
Their website has a general contact form; we send your quote request through it.
What they offer
Process development
Supports early-stage programs with platform fit, construct optimization, and production strategy, and supports late-stage programs with comparability studies, next-generation process transition, and process characterization/PPQ.
AAV manufacturing platform
Uses the Aava™ platform and Pro10™ cell line to manufacture AAV gene therapies with a high-yield, scalable process.
Early phase production
Produces material for development, toxicology, and Phase I clinical needs from small screening batches through cGMP batches.
Late phase production
Provides manufacturing support for late-stage clinical development and commercialization, including process characterization and PPQ planning.
Commercial production
Provides large-scale AAV manufacturing for commercial supply, including scale-up and scale-out to meet demand.
Fill and finish
Performs fill and finish in dedicated suites with automated isolator-based operations.
QC release
Carries out quality control release work, with much of the QC and CMC work performed in-house.
MSAT services
Supports manufacturing science and technology activities, including process characterization and scale-down studies.
Plasmid DNA production
Provides plasmid DNA production as part of the AAV manufacturing workflow.
What they work on
- Modalities
- Viral vector, Cell therapy, Plasmid DNA
- Species and models
- HEK293-derived cell line, Pro10™ suspension cell line
- Assays and studies
- ELISA, DNA analysis, physicochemical testing, analytical characterization, process characterization
- Instruments and platforms
- Ambr250 HT system, ultracentrifugation, depth filtration, chromatography skids, tangential flow filtration
- Scale and capacity
- 2L screening batches, 50L toxicology batches, 250L-500L cGMP batches, up to 1,500L per batch, up to 2,000L single-use bioreactors per suite, 3 modules, up to 3 production trains per module, 343,000+ square feet, 45,000 square feet of clinical-stage infrastructure, 300,000+ square feet of commercial readiness, 1000m2 MSAT cGMP-like laboratory
- Therapeutic areas
- gene therapy, rare diseases, ultra-rare diseases, pathway diseases, drug-resistant focal epilepsy, Spastic Paraplegia 50, Charcot-Marie-Tooth disease type 4J, AADC deficiency, NPC, NPA, Duchenne muscular dystrophy exon 1 deletion, MPS IIIC
- Type
- CDMO
- Sites
- San Sebastián, Spain
- Team
- 400+ professionals
- Quality
- cGMP certification by AEMPS (manufacture of human medicinal products, investigational medicinal products and sterile or biological active substances) · EMA cGMP certified through Phase 3 (clinical operations and commercial readiness) · 100% success rate on IND/IMPD dossier su
- Founded
- 2017
Similar labs. AGC Biologics, Esco Aster, eXmoor Pharma, Minaris
Found in a contract services directory. Listing built from viralgen.com. Work here? Claim this listing.